Database Commons a catalog of biological databases

Database Commons - SurvExpress

SurvExpress

Citations: 37

z-index 5.40

Short name SurvExpress
Full name
Description The SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets.
URL http://bioinformatica.mty.itesm.mx:8080/Biomatec/SurvivaX.jsp
Year founded 2013
Last update & version 2015-01-01    v2.0
Availability Free to all users
University/Institution hosted Monterrey Institute of Technology and Higher Education
Address Monterrey, Nuevo León, México
City Monterrey
Province/State
Country/Region Mexico
Contact name Victor Trevino
Contact email vtrevino@itesm.mx
Data type(s)
Major organism(s)
Keyword(s)
  • cancer gene expression
  • online biomarker
Publication(s)
  • SurvExpress: an online biomarker validation tool and database for cancer gene expression data using survival analysis. [PMID: 24066126]

    Raul Aguirre-Gamboa, Hugo Gomez-Rueda, Emmanuel Martínez-Ledesma, Antonio Martínez-Torteya, Rafael Chacolla-Huaringa, Alberto Rodriguez-Barrientos, José G Tamez-Peña, Victor Treviño
    PloS one 2013:8(9)
    37 Citations (Google Scholar as of 2016-06-09)

    Abstract: Validation of multi-gene biomarkers for clinical outcomes is one of the most important issues for cancer prognosis. An important source of information for virtual validation is the high number of available cancer datasets. Nevertheless, assessing the prognostic performance of a gene expression signature along datasets is a difficult task for Biologists and Physicians and also time-consuming for Statisticians and Bioinformaticians. Therefore, to facilitate performance comparisons and validations of survival biomarkers for cancer outcomes, we developed SurvExpress, a cancer-wide gene expression database with clinical outcomes and a web-based tool that provides survival analysis and risk assessment of cancer datasets. The main input of SurvExpress is only the biomarker gene list. We generated a cancer database collecting more than 20,000 samples and 130 datasets with censored clinical information covering tumors over 20 tissues. We implemented a web interface to perform biomarker validation and comparisons in this database, where a multivariate survival analysis can be accomplished in about one minute. We show the utility and simplicity of SurvExpress in two biomarker applications for breast and lung cancer. Compared to other tools, SurvExpress is the largest, most versatile, and quickest free tool available. SurvExpress web can be accessed in http://bioinformatica.mty.itesm.mx/SurvExpress (a tutorial is included). The website was implemented in JSP, JavaScript, MySQL, and R.

Community reviews

Data
quality & quantity
Content organization & presentation
System accessibility & reliability
Reviewed by

Word cloud (embeddable)

Database Commons - Word Cloud

Accessibility

Rate of accessibility:
HTTP status codeDate requested
200 OK2018-11-16
200 OK2018-11-13
200 OK2018-11-09
200 OK2018-11-06
200 OK2018-11-02
200 OK2018-10-30
200 OK2018-10-26
200 OK2018-10-23
200 OK2018-10-19
200 OK2018-10-16
200 OK2018-10-12
200 OK2018-10-09
200 OK2018-10-05
200 OK2018-10-02
-1 Failed2018-09-28
-1 Failed2018-09-25
-1 Failed2018-09-21
-1 Failed2018-09-18
-1 Failed2018-09-14
-1 Failed2018-09-11
-1 Failed2018-09-07
-1 Failed2018-09-04
-1 Failed2018-08-31
-1 Failed2018-08-28
-1 Failed2018-08-24
-1 Failed2018-08-21
-1 Failed2018-08-17
-1 Failed2018-08-14
-1 Failed2018-08-10
200 OK2018-08-07
200 OK2018-08-03
200 OK2018-07-31
200 OK2018-07-27
200 OK2018-07-24
-1 Failed2018-07-20
-1 Failed2018-07-17
200 OK2018-07-13
200 OK2018-07-10
200 OK2018-07-06
200 OK2018-07-03
200 OK2018-06-29
200 OK2018-06-26
200 OK2018-06-22
200 OK2018-06-19
200 OK2018-06-15
200 OK2018-06-12
200 OK2018-06-08
200 OK2018-06-05
200 OK2018-06-01
200 OK2018-05-29
200 OK2018-05-25
200 OK2018-05-22
200 OK2018-05-18
200 OK2018-05-15
200 OK2018-05-11
200 OK2018-05-08
200 OK2018-05-04
200 OK2018-05-01
200 OK2018-04-27
200 OK2018-04-24
200 OK2018-04-20
200 OK2018-04-17
200 OK2018-04-13
200 OK2018-04-10
200 OK2018-04-06
200 OK2018-04-03
200 OK2018-02-27
200 OK2018-02-23
200 OK2018-02-20
200 OK2018-02-16
200 OK2018-02-13
200 OK2018-02-09
200 OK2018-02-06
200 OK2018-02-02
200 OK2018-01-30
200 OK2018-01-26
200 OK2018-01-23
200 OK2018-01-19
200 OK2018-01-16
200 OK2018-01-12
200 OK2018-01-09
200 OK2018-01-05
200 OK2018-01-02
200 OK2017-12-29
200 OK2017-12-26
200 OK2017-12-22
200 OK2017-12-19
200 OK2017-12-15
200 OK2017-12-12
200 OK2017-12-08
200 OK2017-12-05
200 OK2017-12-01
200 OK2017-11-28
200 OK2017-11-24
200 OK2017-11-21
200 OK2017-11-17
200 OK2017-11-14
200 OK2017-11-10
200 OK2017-11-07
200 OK2017-11-03
200 OK2017-10-31
200 OK2017-10-27
200 OK2017-10-24
200 OK2017-10-20
200 OK2017-10-17
200 OK2017-10-13
200 OK2017-10-10
200 OK2017-10-06
200 OK2017-10-03
200 OK2017-09-29
200 OK2017-09-26
200 OK2017-09-22
200 OK2017-09-19
200 OK2017-09-15
200 OK2017-09-12
200 OK2017-09-08
200 OK2017-09-05
200 OK2017-09-01
200 OK2017-08-29
200 OK2017-08-25
200 OK2017-08-22
200 OK2017-08-18
200 OK2017-08-15
200 OK2017-08-11
200 OK2017-08-08
200 OK2017-08-04
200 OK2017-08-01
200 OK2017-07-28
200 OK2017-07-25
200 OK2017-07-21
200 OK2017-07-18
200 OK2017-07-14
200 OK2017-07-04
200 OK2017-06-30
200 OK2017-06-27
200 OK2017-06-23
200 OK2017-06-20
200 OK2017-06-16
200 OK2017-06-13
200 OK2017-06-09
200 OK2017-06-06
200 OK2017-06-02
200 OK2017-05-30
200 OK2017-05-26
200 OK2017-05-23
200 OK2017-05-19
200 OK2017-05-16
200 OK2017-05-12
200 OK2017-05-09
200 OK2017-05-05
200 OK2017-05-02
200 OK2017-04-28
200 OK2017-04-25
200 OK2017-04-21
200 OK2017-04-18
200 OK2017-04-14
200 OK2017-04-11
200 OK2017-04-07
200 OK2017-04-04
200 OK2017-03-31
200 OK2017-03-28
200 OK2017-03-24
200 OK2017-03-21
200 OK2017-03-17
200 OK2017-03-14
200 OK2017-03-10
200 OK2017-03-07
200 OK2017-03-03
200 OK2017-02-28
200 OK2017-02-24
200 OK2017-02-21
200 OK2017-02-17
200 OK2017-02-14
-1 Failed2017-02-10
200 OK2017-02-07
200 OK2017-02-03
200 OK2017-01-31
200 OK2017-01-27
200 OK2017-01-24
200 OK2017-01-20
200 OK2017-01-17
200 OK2017-01-13
200 OK2017-01-10
200 OK2017-01-06
200 OK2017-01-03
200 OK2016-12-30
200 OK2016-12-27
200 OK2016-12-23
200 OK2016-12-20
200 OK2016-12-16
200 OK2016-12-13
200 OK2016-12-09
200 OK2016-12-06
200 OK2016-12-02
200 OK2016-11-29
200 OK2016-11-25
200 OK2016-11-22
200 OK2016-11-18
200 OK2016-11-15
200 OK2016-11-11
200 OK2016-11-08
200 OK2016-11-04
200 OK2016-11-01
200 OK2016-10-28
-1 Failed2016-10-25
-1 Failed2016-10-21
-1 Failed2016-10-18
-1 Failed2016-10-14
200 OK2016-10-11
200 OK2016-10-07
200 OK2016-10-04
200 OK2016-09-30
200 OK2016-09-27
200 OK2016-09-23
200 OK2016-09-20
200 OK2016-09-16
200 OK2016-09-13
200 OK2016-09-09
200 OK2016-09-06
200 OK2016-09-02
200 OK2016-08-30
200 OK2016-08-26
200 OK2016-08-23
200 OK2016-08-19
200 OK2016-08-16
200 OK2016-08-12
200 OK2016-08-09
200 OK2016-08-05
200 OK2016-08-02
200 OK2016-07-29
200 OK2016-07-26
200 OK2016-07-22
200 OK2016-07-19
200 OK2016-07-15
200 OK2016-07-12
200 OK2016-07-08
200 OK2016-07-05
200 OK2016-07-01
200 OK2016-06-28
200 OK2016-06-24
200 OK2016-06-21
200 OK2016-06-17
200 OK2016-06-14
200 OK2016-06-10
200 OK2016-06-07
200 OK2016-06-03
200 OK2016-05-31
200 OK2016-05-27
-1 Failed2016-05-24
-1 Failed2016-05-20
-1 Failed2016-05-17
-1 Failed2016-05-13
-1 Failed2016-05-10
-1 Failed2016-05-06
-1 Failed2016-05-03
-1 Failed2016-04-29
-1 Failed2016-04-26
-1 Failed2016-04-22
-1 Failed2016-04-19
-1 Failed2016-04-15
-1 Failed2016-04-12
-1 Failed2016-04-08
-1 Failed2016-04-05
-1 Failed2016-04-01
-1 Failed2016-03-29
-1 Failed2016-03-28
-1 Failed2016-03-25
-1 Failed2016-03-23
-1 Failed2016-03-21
-1 Failed2016-03-18
-1 Failed2016-03-16
-1 Failed2016-03-14
-1 Failed2016-03-11
-1 Failed2016-03-09
-1 Failed2016-03-07
-1 Failed2016-03-04
-1 Failed2016-03-02
-1 Failed2016-02-29
-1 Failed2016-02-26
-1 Failed2016-02-24
-1 Failed2016-02-22
-1 Failed2016-02-19
-1 Failed2016-02-17
-1 Failed2016-02-15
-1 Failed2016-02-14
-1 Failed2016-02-12
-1 Failed2016-02-10
-1 Failed2016-02-08
-1 Failed2016-02-07
-1 Failed2016-02-05
-1 Failed2016-02-03
-1 Failed2016-02-01
-1 Failed2016-01-31
-1 Failed2016-01-29
-1 Failed2016-01-27
-1 Failed2016-01-25
-1 Failed2016-01-24
-1 Failed2016-01-22
-1 Failed2016-01-20
-1 Failed2016-01-18
-1 Failed2016-01-17
-1 Failed2016-01-15
-1 Failed2016-01-13
-1 Failed2016-01-11
-1 Failed2016-01-10
-1 Failed2016-01-08
-1 Failed2016-01-06
-1 Failed2016-01-04

Tags

Disease DNA Expression
Homo sapiens
cancer gene expression online biomarker

Record metadata

  • Created on: 2015-06-30
  • Curated by:
    • Lin Xia [2016-03-28]
    • Mengwei Li [2015-12-29]
Stats